Vital Therapies (VTL) Reports In-Line Q1 EPS

Vital Therapies (NASDAQ: VTL) reported Q1 EPS of ($0.34), in-line with the analyst estimate of ($0.34).

For earnings history and earnings-related data on Vital Therapies (VTL) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
• Jack Henry (JKHY) Tops Q4 EPS by 13c